HAEMONETICS CORP - Common Stock (HAE)

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / Common Stock
Shares outstanding
47,898,935
Total 13F shares
54,173,562
Share change
-445,145
Total reported value
$1,765,475,443
Put/Call ratio
326%
Price per share
$32.59
Number of holders
187
Value change
-$102,994,220
Number of buys
97
Number of sells
98

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2014

As of 31 Mar 2014 HAEMONETICS CORP - Common Stock (HAE) had 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 54,173,562 shares of stock of the company.
Largest 10 holders included Neuberger Berman Group LLC, VANGUARD GROUP INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Fund Advisors, FMR LLC, PRUDENTIAL PLC, BlackRock Institutional Trust Company, N.A., Van Berkom & Associates Inc., SNYDER CAPITAL MANAGEMENT L P, and Camber Capital Management LLC.
This table shows 187 institutional shareholders of the security as of 31 Mar 2014.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.